BPN.F - Medibio Limited

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue6/30/20186/30/20176/30/20166/30/2015
Total Revenue2,462.0913,122.3241,757.131255.12
Cost of Revenue75.669---
Gross Profit2,386.4223,122.3241,757.131255.12
Operating Expenses
Research Development3,255.2454,320.9341,853.268210.664
Selling General and Administrative7,090.3781,958.364810.532492.435
Non Recurring----
Others7,142.0824,668.9223,390.3242,497.42
Total Operating Expenses18,892.83512,674.9787,315.9493,716.98
Operating Income or Loss-16,430.744-9,552.654-5,558.818-3,461.86
Income from Continuing Operations
Total Other Income/Expenses Net130.362-232.418-265.553-4,459.842
Earnings Before Interest and Taxes-16,430.744-9,552.654-5,558.818-3,461.86
Interest Expense-8.139-266.659-313.455-160.622
Income Before Tax-16,300.382-9,785.072-5,824.371-7,921.702
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-16,300.382-9,785.072-5,824.371-7,921.702
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-16,300.382-9,785.072-5,824.371-7,921.702
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-16,300.382-9,785.072-5,824.371-7,921.702